Related references
Note: Only part of the references are listed.Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors
Stanley N. Caroff
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2020)
Recent developments in drug-induced movement disorders: a mixed picture
Stewart A. Factor et al.
LANCET NEUROLOGY (2019)
The Assessment and Treatment of Antipsychotic-Induced Akathisia
Tamara Pringsheim et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2018)
Revisiting the Abnormal Involuntary Movement Scale: Proceedings From the Tardive Dyskinesia Assessment Workshop
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Historical perspectives on tardive dyskinesia
Stanley N. Caroff et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Future directions in tardive dyskinesia research
Jonathan M. Meyer
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Tardive dyskinesia: Out of the shadows
Robert A. Hauser et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
The nosology of tardive syndromes
Karen Frei et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
VMAT2 inhibitors for the treatment of tardive dyskinesia
Laura M. Scorr et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm
Roongroj Bhidayasiri et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Clinical risk factors for the development of tardive dyskinesia
Marco Solmi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Tardive syndromes
Daniel Savitt et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities
Yona Lunsky et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2018)
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive DyskinesiaKey Differences in Pathophysiology and Clinical Management
Kristen M. Ward et al.
NEUROLOGY AND THERAPY (2018)
Pharmacological treatment of tardive dyskinesia: recent developments
Stanley N. Caroff et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Epidemiology and Prevention of Tardive Dyskinesia
Christoph U. Correll
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis
Maren Carbon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
A Validation Study of the International Consensus Diagnostic Criteria for Neuroleptic Malignant Syndrome
Ronald J. Gurrera et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Randomized controlled trial of deutetrabenazine for tardive dyskinesia The ARM-TD study
Hubert H. Fernandez et al.
NEUROLOGY (2017)
Cognitive burden of anticholinergic medications in psychotic disorders
Seenae Eum et al.
SCHIZOPHRENIA RESEARCH (2017)
Pharmacological treatment of tardive dyskinesia: recent developments
Stanley N. Caroff et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial
Karen E. Anderson et al.
LANCET PSYCHIATRY (2017)
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia
Robert A. Hauser et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia
Jonathan M. Meyer
CNS SPECTRUMS (2016)
Drug-Induced Extrapyramidal Syndromes Implications for Contemporary Practice
Stanley N. Caroff et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2016)
Drug-induced movement disorders
Denes Zadori et al.
EXPERT OPINION ON DRUG SAFETY (2015)
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
Christopher F. O'Brien et al.
MOVEMENT DISORDERS (2015)
Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study
Rory Sheehan et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study
Rory Sheehan et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Lithium tremor revisited: pathophysiology and treatment
J. H. Baek et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
Tardive Dyskinesia: Therapeutic Options for an Increasingly Common Disorder
Leslie J. Cloud et al.
NEUROTHERAPEUTICS (2014)
Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism
James F. Morley et al.
PARKINSONISM & RELATED DISORDERS (2014)
Evidence-based guideline: Treatment of tardive syndromes Report of the Guideline Development Subcommittee of the American Academy of Neurology
Roongroj Bhidayasiri et al.
NEUROLOGY (2013)
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs
Michael J. Peluso et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Tardive dyskinesia is caused by maladaptive synaptic plasticity: A hypothesis
James T. Teo et al.
MOVEMENT DISORDERS (2012)
Movement Disorders Induced by Antipsychotic Drugs: Implications of the CATIE Schizophrenia Trial
Stanley N. Caroff et al.
NEUROLOGIC CLINICS (2011)
Acute antipsychotic-induced akathisia revisited
Michael Poyurovsky
BRITISH JOURNAL OF PSYCHIATRY (2010)
Incidence of Tardive Dyskinesia With Atypical Versus Conventional Antipsychotic Medications: A Prospective Cohort Study
Scott W. Woods et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Akathisia: An Updated Review Focusing on Second-Generation Antipsychotics
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Drug induced parkinsonism: a common cause of parkinsonism in older people
B. Thanvi et al.
POSTGRADUATE MEDICAL JOURNAL (2009)
Association between selective serotonin-reuptake inhibitors, second-generation antipsychotics, and neuroleptic malignant syndrome
Debra L. Stevens
ANNALS OF PHARMACOTHERAPY (2008)
Tardive Dyskinesia and the 3-Year Course of Schizophrenia: Results From a Large, Prospective, Naturalistic Study
Haya Ascher-Svanum et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Chronic restlessness with antipsychotics
Irene M. Bratti et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Movement disorders in patients taking anticonvulsants
C. Zadikoff et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease
M Lorberboym et al.
MOVEMENT DISORDERS (2006)
The serotonin syndrome
EW Boyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Fluoxetine-induced tremor:: clinical features in 21 patients
A Serrano-Dueñas
PARKINSONISM & RELATED DISORDERS (2002)
Effects of newer Antipsychotics on extrapyramidal function
D Tarsy et al.
CNS DRUGS (2002)
Share Paper
